Themes
Cocrystal receives approval from HREC for Phase I trial of Covid-19 therapy
CDI-988 demonstrated in vitro potency against SARS-CoV-2 and other coronaviruses.
Role of machine learning tools in early diagnosis of Parkinson’s disease
Shionogi starts Phase I trial of Covid-19 antiviral in Japan
It’s a match! Connecting patients to clinical trials with AI
Netramark unveils ChatGPT-based clinical trial de-risking technology
Navigating uncertainty: How Covid-19 has changed the CRO and sponsor dynamic
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
